Wholesale of pharmaceutical and medical goods
SCANVACC AS
Revenue 2024
NOK 103,000
Operating profit
NOK −6.7m
Equity
NOK 40.4m
Incorporated
1997
Share capital
NOK 160,000
Key figures · 2024
Current ratio
22.21
Equity ratio
97.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -6474.7% | |
| Net margin (%%) | -5713.4% | |
| Return on assets (%%) | -16.2% | |
| Likviditet | ||
| Current ratio | 22.21 | |
| Working capital | 21.0m | |
| Soliditet | ||
| Equity ratio (%%) | 97.6% | |
| Debt-to-equity ratio | 0.02 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.